Loading insider details...
Beta
Latest Form 4 (Jan 7, 2026): Grant/Award of 2,500 DRMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 7, 2026 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 2,500 | n/a |
| Jan 23, 2025 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 78,741 | n/a |
| Jan 14, 2025 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 5,000 | n/a |
| Jun 24, 2024 | Oncternal Therapeutics, Inc. (ONCT) | Grant/Award | 3,300 | n/a |
| Feb 27, 2024 | Oncternal Therapeutics, Inc. (ONCT) | Purchase | 714 | $6.5K |
| Jan 5, 2024 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 10,000 | n/a |
| Oct 7, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 30,155 | n/a |
| Jul 8, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 26,441 | n/a |
| Apr 8, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 15,466 | n/a |
| Jan 6, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 5,000 | n/a |